Section 8.1
Antiulcer Drugs & Acid Suppression
Explain how acid suppression, mucosal protection and H. pylori treatment address different ulcer mechanisms, then apply pregnancy and interaction safety reasoning.
Learn
Idea 1 / 4
Acid is one part of ulcer balance
Peptic ulcers arise when damaging influences such as acid, pepsin, H. pylori or NSAIDs outweigh mucosal defenses. H2 antagonists reduce histamine-driven acid secretion at parietal-cell H2 receptors. Proton pump inhibitors (PPIs) block the final H+/K+ ATPase step more powerfully and for longer. Reducing acid supports healing but does not eradicate H. pylori by itself.
A patient with confirmed H. pylori needs an eradication regimen, not only a PPI for symptom relief.
Read all essential notes
Acid is one part of ulcer balance
Peptic ulcers arise when damaging influences such as acid, pepsin, H. pylori or NSAIDs outweigh mucosal defenses. H2 antagonists reduce histamine-driven acid secretion at parietal-cell H2 receptors. Proton pump inhibitors (PPIs) block the final H+/K+ ATPase step more powerfully and for longer. Reducing acid supports healing but does not eradicate H. pylori by itself.
A patient with confirmed H. pylori needs an eradication regimen, not only a PPI for symptom relief.
Protection and eradication are different jobs
Sucralfate forms a local protective barrier over an ulcer in an acidic environment. Misoprostol is a prostaglandin E1 analogue that strengthens mucosal defenses and reduces acid, and may prevent NSAID-related ulcers. H. pylori regimens combine acid suppression with antibiotics and bismuth or another approved component; each part has a distinct role.
Sucralfate can protect a lesion, while antibiotics are needed when bacterial eradication is the goal.
Pregnancy changes the misoprostol decision
Misoprostol can cause uterine contractions and pregnancy loss. It is therefore contraindicated for NSAID-ulcer prevention during pregnancy, and people who could become pregnant need the label’s pregnancy precautions. A medication’s ability to protect the stomach does not override a serious reproductive hazard.
A pregnant person needing NSAID protection requires a different clinical plan rather than self-starting misoprostol.
Interactions can change the practical choice
Cimetidine inhibits several hepatic CYP pathways and can raise concentrations of other medicines. PPIs and H2 antagonists also change gastric conditions that affect some absorption. Review the complete medication list and the treatment target instead of treating every acid suppressant as interchangeable.
A person taking several narrow-therapeutic-index medicines may need review before choosing cimetidine.
Common misconception: “Every acid medicine treats H. pylori.” Acid suppression can support healing, but eradication requires antimicrobial therapy in an appropriate regimen.
Explore
Follow the mechanism. Select a step to explain what changes and why. This is a schematic, not a physiological simulation.
Step 1 / 4
Identify the ulcer driver
Separate acid excess, NSAID injury, mucosal weakness and H. pylori infection before choosing a class.
Go deeper: worked example
A patient with H. pylori-positive ulcer also takes several medicines metabolized by the liver. A pregnant partner asks whether she can use the patient’s misoprostol for “stomach protection.” What must be separated?
- H. pylori changes the goal from acid relief alone to eradication with an appropriate combination regimen.
- The medication list matters because cimetidine can inhibit CYP metabolism and change exposure to other drugs.
- Misoprostol’s mucosal benefit does not make it safe in pregnancy; uterine effects create a serious reproductive hazard.
- The safe next step is clinician or pharmacist review of the infection regimen, interactions and pregnancy-safe alternative, without sharing prescriptions.
The best plan matches the cause and checks context. Acid reduction, bacterial eradication, interaction review and pregnancy safety are separate decisions.
Explain it yourself
Why can a stomach-protective medicine still be unsafe in pregnancy?
Reveal explanation
Misoprostol improves mucosal defense but also acts on uterine smooth muscle and can cause pregnancy loss. Therapeutic benefit in one organ does not cancel a serious reproductive effect.
Create and evaluate
Create a decision map comparing an H2 blocker, a PPI, sucralfate, misoprostol and an H. pylori regimen.
Formative activity: compare your reasoning with the rubric. This response is not automatically graded and does not award mastery. It remains only on this page and is cleared when you leave.
Compare with the rubric and example
- Mechanism: place acid suppression, mucosal protection and antimicrobial action at their correct sites.
- Cause: match H. pylori and NSAID-related injury to a rationale rather than one universal drug.
- Safety: include pregnancy, interaction and persistent-symptom checks.
A PPI or H2 blocker reduces acid; sucralfate shields a lesion; misoprostol supports mucosa but is unsafe in pregnancy; H. pylori needs antimicrobial eradication plus acid control. Cimetidine interactions and alarm symptoms require review.
Sources and review status
Educational draft. Medical and French-language expert review pending. External sources require an internet connection; essential explanations are included above.
- Clinical Pharmacology Made Incredibly Easy!, 3rd ed. (2009)
Chapter 8, printed pp. 195–214; PDF pp. 207–226 (1-based; GI mechanisms and classes).
- DailyMed: Cytotec (misoprostol) tablets
Current label, accessed 2026-09-21: pregnancy warning, uterine contractions and NSAID-ulcer prevention.
- DailyMed: metoclopramide tablets
Current label, accessed 2026-09-21: tardive dyskinesia boxed warning, duration limits and gastroparesis indication.
- DailyMed: orlistat capsules
Current label, accessed 2026-09-21: reduced fat absorption, gastrointestinal effects and fat-soluble vitamin supplementation.
- DailyMed: PANCREAZE (pancrelipase) delayed-release capsules
Current label, accessed 2026-09-21: pancreatic exocrine insufficiency, lipase-unit dosing and monitoring.
- American College of Gastroenterology: H. pylori guideline highlights (2024)
Guideline highlights, accessed 2026-09-21: treat confirmed infection with an eradication regimen and confirm eradication after treatment; acid suppression alone is not eradication therapy.
- DailyMed: cimetidine tablets
Current label, accessed 2026-09-21: reduced hepatic metabolism and increased blood levels of listed co-medications, including drugs with a low therapeutic ratio.
- DailyMed: loperamide hydrochloride tablets
Current label, accessed 2026-09-21: controls diarrhea symptoms; do not use with bloody or black stool and seek advice with fever, mucus in stool, liver disease, or abnormal heart rhythm.
- DailyMed: ondansetron tablets
Current label, accessed 2026-09-21: 5-HT3 antiemetic indications; QT prolongation/Torsade reports; avoid in congenital long-QT syndrome and monitor selected patients with electrolyte, cardiac, bradyarrhythmia, or other QT-prolonging-drug risks.
Check my understanding
Mastery Question Gate
Answer all questions correctly to unlock the next lesson. Retakes vary the selection when enough questions are available; some questions may repeat.
1. Why is misoprostol strictly contraindicated during pregnancy?